Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;38(7):1297-1306.
doi: 10.1007/s00381-022-05511-w. Epub 2022 Apr 1.

Clinical predictors of survival for patients with atypical teratoid/rhabdoid tumors

Affiliations

Clinical predictors of survival for patients with atypical teratoid/rhabdoid tumors

Vismaya S Bachu et al. Childs Nerv Syst. 2022 Jul.

Abstract

Purpose: Atypical teratoid/rhabdoid tumors (AT/RTs) are malignant central nervous system (CNS) neoplasms of the young. Our study analyzed a large AT/RT cohort from the National Cancer Database (NCDB) to elucidate predictors of short-term mortality and overall survival (OS).

Methods: Information was collected on patients with histologically confirmed AT/RT using the NCDB (2004-2016). Kaplan-Meier analysis indicated OS. Prognostic factors for 30-day mortality, 90-day mortality, and OS were determined via multivariate Cox proportional hazards (CPH) and logistic regression models.

Results: Our cohort of 189 patients had a median age of 1 year (IQR [1, 4]) and tumor size of 4.7 ± 2.0 cm at diagnosis. Seventy-two percent were under 3 years old; 55.6% were male and 71.0% were Caucasian. Fifty (27.2%) patients received only surgery (S) (OS = 5.91 months), 51 (27.7%) received surgery and chemotherapy (S + CT) (OS = 11.2 months), and 9 (4.89%) received surgery and radiotherapy (S + RT) (OS = 10.3 months). Forty-five (24.5%) received S + CT + RT combination therapy (OS = 45.4 months), 13 (17.1%) received S + CT + BMT/SCT (bone marrow or stem cell transplant) (OS = 55.5 months), and 16 (8.70%) received S + CT + RT + BMT/SCT (OS = 68.4 months). Bivariate analysis of dichotomized age (HR = 0.550, 95% CI [0.357, 0.847], p = 0.0067) demonstrated significantly increased patient survival if diagnosed at or above 1 year old. On multivariate analysis, administration of S + CT + RT, S + CT + BMT/SCT, or S + CT + RT + BMT/SCT combination therapy predicted significantly (p < 0.05) increased OS compared to surgery alone.

Conclusion: AT/RTs are CNS tumors where those diagnosed under 1 year old have a significantly worse prognosis. Our study demonstrates that while traditional CT, RT, and BMT/SCT combination regimens prolong life, overall survival in this population is still low.

Keywords: National Cancer Database Study; Pediatric NCDB; Pediatric brain tumor; Pediatric tumor.

PubMed Disclaimer

References

    1. Atypical Teratoid Rhabdoid Tumors (ATRT) Diagnosis and Treatment - National Cancer Institute. https://www.cancer.gov/rare-brain-spine-tumor/tumors/atrt . Accessed 9 Mar 2021
    1. Richardson EA, Ho B, Huang A (2018) Atypical teratoid rhabdoid tumour: from tumours to therapies. J Korean Neurosurg Soc 61:302–311 - DOI
    1. Lau CSM, Mahendraraj K, Chamberlain RS (2015) Atypical teratoid rhabdoid tumors: a population-based clinical outcomes study involving 174 patients from the Surveillance, Epidemiology, and End Results database (1973–2010). Cancer Manag Res 7:301–309. https://doi.org/10.2147/CMAR.S88561 - DOI - PubMed - PMC
    1. Quinn TJ, Almahariq MF, Siddiqui ZA, Thompson AB, Hamstra DA, Kabolizadeh P, Gowans KL, Chen PY (2019) Trimodality therapy for atypical teratoid/rhabdoid tumor is associated with improved overall survival: a surveillance, epidemiology, and end results analysis. Pediatr Blood Cancer. https://doi.org/10.1002/pbc.27969 - DOI - PubMed - PMC
    1. National Cancer Database. https://www.facs.org/Quality-Programs/Cancer/NCDB . Accessed 18 Feb 2021

LinkOut - more resources